Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohort

BackgroundIn most studies, the autosomal dominant (type II) form of isolated growth hormone deficiency (IGHD) has been more frequent than the autosomal recessive (type I) form.Our aim was to assess defects in the GH1 in short Brazilian children with different GH secretion status.Subjects and methodsWe selected 135 children with postnatal short stature and classified according to the highest GH peak at stimulation tests in: severe IGHD (peak GH ≤ 3.3 μg/L, n = 38, all with normal pituitary magnetic resonance imaging); GH peak between 3.3 and 10 μg/L (n = 76); and GH peak > 10 μg/L (n = 21). The entire coding region of GH1 was sequenced and complete GH1 deletions were assessed by Multiplex Ligation Dependent Probe Amplification and restriction enzyme digestion.ResultsPatients with severe IGHD had a higher frequency of consanguinity, were shorter, had lower levels of IGF-1 and IGFBP-3, and despite treatment with lower GH doses had a greater growth response than patients with GH peak ≥ 3.3 μg/L. Mutations were found only in patients with severe IGHD (GH peak < 3.3 μg/L). Eight patients had autosomal recessive IGHD: Seven patients were homozygous for GH1 deletions and one patient was compound heterozygous for a GH1 deletion and the novel c.171 + 5G > C point mutation in intron 2, predicted to abolish the donor splice site. Only one patient, who was heterozygous for the c.291 + 1G > T mutation located at the universal donor splice site of intron 3 and predicts exon 3 skipping, had an autosomal dominant form.ConclusionAnalysis of GH1 in a cohort of Brazilian patients revealed that the autosomal recessive form of IGHD was more common than the dominant one, and both were found only in severe IGHD.